Evidence map›Paper›PMID 29290138›Full record

ReviewThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2018

Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.

Paul O'Callaghan, Xiao Zhang, Jin-Ping Li

Open access · bronzeAbstract readReview
In one paragraph

Review in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Osteochondroma formation is independent of heparanase expression as revealed in a mouse model of hereditary multiple exostoses.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2022
    Article
  14. Article
  15. Role of extracellular matrix proteoglycans in immune cell recruitment.International journal of experimental pathology · 2022
    Review
  16. Review
  17. Review
  18. Differences in MPS I and MPS II Disease Manifestations.International journal of molecular sciences · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Paul O'CallaghanDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-3117-5367
Xiao ZhangDepartment of Neuroscience, Uppsala University, Uppsala, Sweden.
Jin-Ping LiDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Uppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heparan sulfate proteoglycans (HSPGs) are implicated as inflammatory mediators in a variety of settings, including chemokine activation, which is required to recruit circulating leukocytes to infection sites. Heparan sulfate (HS) polysaccharide chains are highly interactive and serve co-receptor roles in multiple ligand:receptor interactions. HS may also serve as a storage depot, sequestering ligands such as cytokines and restricting their access to binding partners. Heparanase, through its ability to fragment HS chains, is a key regulator of HS function and has featured prominently in studies of HS's involvement in inflammatory processes. This review focuses on recent discoveries regarding the role of HSPGs, HS, and heparanase during inflammation, with particular focus on the brain. HS chains emerge as critical go-betweens in multiple aspects of the inflammatory response-relaying signals between receptors and cells. The molecular interactions proposed to occur between HSPGs and the pathogen receptor toll-like receptor 4 (TLR4) are discussed, and we summarize some of the contrasting roles that HS and heparanase have been assigned in diseases associated with chronic inflammatory states, including Alzheimer's disease (AD). We conclude by briefly discussing how current knowledge could potentially be applied to augment HS-mediated events during sustained neuroinflammation, which contributes to neurodegeneration in AD.

Indexed as

Immunity, InnateAlzheimer DiseaseAnimalsBrainCytokinesGlucuronidaseHeparanaseHeparan SulfateHeparan Sulfate ProteoglycansHumansInflammationNeurogliaNeuroimmunomodulationToll-Like Receptor 4CytokinesGlucuronidaseHeparanaseHeparan SulfateHeparan Sulfate ProteoglycansToll-Like Receptor 4Alzheimer’s disease (AD)extracellular matrix (ECM)heparanaseheparan sulfate (HS)heparan sulfate proteoglycans (HSPGs)inflammationinnate immunitymicroglianeuroinflammationtoll-like receptor 4 (TLR4)

Identifiers

PMID29290138
PMCPMC5958378
OpenAlexW2781911700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.